Verus Capital Partners’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$21K Sell
2,000
-2,500
-56% -$31.8K 0.01% 788
2019
Q4
$81K Buy
+4,500
New +$66.5K 0.03% 443

Other funds holding AXGN

Verus Capital Partners's AXGN Position: Q1 2020 in Review

Verus Capital Partners reduced its Axogen (AXGN) stake by 56% in Q1 2020, selling an estimated $31.8K and leaving 2,000 shares worth $21K. The position accounts for 0.01% of the portfolio, ranked #788.

Verus Capital Partners first reported a position in AXGN in Q4 2019 and has held it in 2 quarters since. The position peaked at $81K in Q4 2019. 116 funds tracked by Wall St. Rank hold AXGN as of Q1 2020.

  • Verus Capital Partners held 2,000 shares of Axogen worth $21K as of Q1 2020.
  • Verus Capital Partners sold 2,500 Axogen shares in Q1 2020, an estimated $31.8K.
  • Axogen made up 0.01% of Verus Capital Partners's portfolio in Q1 2020, its #788 holding.
  • Verus Capital Partners first reported a position in Axogen in Q4 2019 and has held it in 2 quarters since.
  • Verus Capital Partners's Axogen position peaked at $81K in Q4 2019.
  • 116 funds tracked by Wall St. Rank held Axogen as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.